Study of immune responses to biologic treatments for psoriatic arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at how people with psoriatic arthritis respond to different types of biologic or targeted synthetic drugs. Participants will be starting a new treatment, and the study will check both clinical symptoms and immune system changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a confirmed diagnosis of psoriatic arthritis (PsA) using standard criteria
- You are about to start a new biologic or targeted synthetic medication for psoriatic arthritis
- You are not switching treatment only for psoriasis or spine inflammation without active joint arthritis
- You have not taken the same biologic drug before that you are starting now
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a personalized treatment plan can help people with psoriasis and psoriatic arthritis, and also looks at how these conditions affect the heart. The goal is to find better ways to treat you and protect your heart health.
This study uses advanced testing to understand inflammation in people with certain chronic inflammatory diseases, such as psoriasis, psoriatic arthritis, other types of arthritis, or inflammatory bowel disease. The goal is to tailor treatment to your specific needs.
This registry is collecting information about people with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis who are starting or needing biologic or targeted medicines. It may help researchers better understand how these treatments work in real life.
This study looks at how well advanced treatments work for people with psoriatic arthritis, and whether results differ for sex and gender. You may be eligible if your psoriatic arthritis is active and you are planning to start an advanced treatment for symptoms in the joints and surrounding areas.
This study tests an oral medication called CBP-0276 for people with active psoriatic arthritis. It compares the new drug to a placebo to see if it helps reduce joint pain and skin symptoms.
This trial is a registry that collects information from adults with plaque psoriasis or psoriatic arthritis who are starting a new biologic or other systemic treatment. It helps researchers understand how these treatments are used in real life and what outcomes they may have.
Hear when a new Psoriasis Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.